Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Luke Pike, Alicia Meng et al.|Lung Cancer|2023Cited by 9
Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).Anna Skakodub, Luke Pike, Kathryn R. Tringale et al.|Journal of Clinical Oncology|2022Cited by 5
Characterization of Central Nervous System&nbsp;Clinico-Genomic Outcomes&nbsp;In&nbsp; <i>ALK</i>-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Luke Pike, Jordan Eichholz et al.|SSRN Electronic Journal|2022Cited by 0
Abstract 6063: Genomic characterization of non-small cell lung cancer (NSCLC) brain metastasis (BM) patients identifies novel alterations associated with tropisms and disease progressionHenry Walch, Luke Pike, Anna Skakodub et al.|Cancer Research|2023Cited by 0
Abstract 3785: Clinical and genomic characterization of melanoma brain metastasesMichel Padilla Mazzeo, Luke Pike, Henry Walch et al.|Cancer Research|2024Cited by 0